Proposed novel therapeutic strategies for AD include both increasing APOE function (APOE mimetics, increasing APOE4 lipidation, small molecule APOE4 structure correctors, APOE2 gene therapy) and reducing APOE expression using antisense oligonucleotides. Here, APOE is linked to Alzheimer disease.